These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 25691059

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. DNA Polymerases as targets for gene therapy of hepatocellular carcinoma.
    Liu H, Wei Q, Wang J, Huang X, Li C, Zheng Q, Cao J, Jia Z.
    BMC Cancer; 2015 Apr 29; 15():325. PubMed ID: 25924900
    [Abstract] [Full Text] [Related]

  • 3. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC, Cao X, Gui JH, Zhou XM, Zhong D, Yan QL, Huang WD, Qian QJ, Zhao FL, Liu XY.
    Hum Gene Ther; 2011 Sep 29; 22(9):1109-19. PubMed ID: 21361790
    [Abstract] [Full Text] [Related]

  • 4. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N, Henderson DR.
    Cancer Res; 2001 Sep 01; 61(17):6428-36. PubMed ID: 11522637
    [Abstract] [Full Text] [Related]

  • 5. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ, Huang R, Kuang AR.
    Cancer Invest; 2009 Jul 01; 27(6):673-81. PubMed ID: 19241193
    [Abstract] [Full Text] [Related]

  • 6. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
    Dai M, Liu J, Chen DE, Rao Y, Tang ZJ, Ho WZ, Dong CY.
    Cancer Gene Ther; 2012 Feb 01; 19(2):77-83. PubMed ID: 21959967
    [Abstract] [Full Text] [Related]

  • 7. Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.
    Yuan X, Zhang Q, Li Z, Zhang X, Bao S, Fan D, Ru Y, Dong S, Zhang Y, Zhang Y, Ye Z, Xiong D.
    Cancer Lett; 2016 Oct 10; 381(1):85-95. PubMed ID: 27450327
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging.
    Park JH, Kim KI, Lee KC, Lee YJ, Lee TS, Chung WS, Lim SM, Kang JH.
    Cancer Biother Radiopharm; 2015 Feb 10; 30(1):8-15. PubMed ID: 25545853
    [Abstract] [Full Text] [Related]

  • 10. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
    Takahashi M, Sato T, Sagawa T, Lu Y, Sato Y, Iyama S, Yamada Y, Fukaura J, Takahashi S, Miyanishi K, Yamashita T, Sasaki K, Kogawa K, Hamada H, Kato J, Niitsu Y.
    Mol Ther; 2002 May 10; 5(5 Pt 1):627-34. PubMed ID: 11991754
    [Abstract] [Full Text] [Related]

  • 11. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study.
    Li W, Li DM, Chen K, Chen Z, Zong Y, Yin H, Xu ZK, Zhu Y, Gong FR, Tao M.
    BMC Cancer; 2012 Nov 23; 12():547. PubMed ID: 23173703
    [Abstract] [Full Text] [Related]

  • 12. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter.
    Cai X, Zhou J, Chang Y, Sun X, Li P, Lin J.
    Cancer Lett; 2008 Jun 08; 264(1):71-82. PubMed ID: 18407409
    [Abstract] [Full Text] [Related]

  • 13. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Cancer Res; 2001 Apr 01; 61(7):3016-21. PubMed ID: 11306481
    [Abstract] [Full Text] [Related]

  • 14. α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy.
    Peng YF, Shi YH, Ding ZB, Zhou J, Qiu SJ, Hui B, Gu CY, Yang H, Liu WR, Fan J.
    PLoS One; 2013 Apr 01; 8(2):e53072. PubMed ID: 23468839
    [Abstract] [Full Text] [Related]

  • 15. A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cells.
    Cao G, Kuriyama S, Tsujinoue H, Chen Q, Mitoro A, Qi Z.
    Int J Cancer; 2000 Jul 15; 87(2):247-52. PubMed ID: 10861483
    [Abstract] [Full Text] [Related]

  • 16. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M.
    Hepatology; 1996 Jun 15; 23(6):1359-68. PubMed ID: 8675152
    [Abstract] [Full Text] [Related]

  • 17. The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells.
    He P, Tang ZY, Liu BB, Ye SL, Liu YK.
    J Cancer Res Clin Oncol; 1999 Jun 15; 125(2):77-82. PubMed ID: 10190313
    [Abstract] [Full Text] [Related]

  • 18. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma.
    Hallenbeck PL, Chang YN, Hay C, Golightly D, Stewart D, Lin J, Phipps S, Chiang YL.
    Hum Gene Ther; 1999 Jul 01; 10(10):1721-33. PubMed ID: 10428217
    [Abstract] [Full Text] [Related]

  • 19. An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma.
    Takikawa H, Mafune K, Hamada H, Nettelbeck DM, Müller R, Makuuchi M, Kaminishi M.
    Int J Oncol; 2003 May 01; 22(5):1051-6. PubMed ID: 12684671
    [Abstract] [Full Text] [Related]

  • 20. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
    Kim KI, Park JH, Lee YJ, Lee TS, Park JJ, Song I, Nahm SS, Cheon GJ, Lim SM, Chung JK, Kang JH.
    J Gene Med; 2012 Aug 01; 14(8):513-20. PubMed ID: 22761128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.